{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06283862",
            "orgStudyIdInfo": {
                "id": "HUM00231159b"
            },
            "secondaryIdInfos": [
                {
                    "id": "VMR2022-03",
                    "type": "OTHER_GRANT",
                    "domain": "Michigan, State of, Licensing and Regulatory Affairs, Department of 573000"
                }
            ],
            "organization": {
                "fullName": "University of Michigan",
                "class": "OTHER"
            },
            "briefTitle": "MIVetsCan: Can-Coach Trial (Phase 2)",
            "officialTitle": "MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 2)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "mivetscan-can-coach-trial-phase"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-21",
            "studyFirstSubmitQcDate": "2024-02-21",
            "studyFirstPostDateStruct": {
                "date": "2024-02-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kevin Boehnke",
                "investigatorTitle": "Research Assistant Professor, Anesthesiology",
                "investigatorAffiliation": "University of Michigan"
            },
            "leadSponsor": {
                "name": "University of Michigan",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Michigan, State of, Licensing and Regulatory Affairs",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.",
            "detailedDescription": "All study interactions will be done virtually."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Pain"
            ],
            "keywords": [
                "Veteran",
                "Cannabis",
                "Cannabidiol"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Participants will be randomized to immediately receive 4 sessions of tailored guidance or to receive it after 12 weeks, as a waitlist control condition.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 468,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Immediate Education",
                    "type": "EXPERIMENTAL",
                    "description": "Education sessions starting \\~ week 4 of trial",
                    "interventionNames": [
                        "Behavioral: Educational Session"
                    ]
                },
                {
                    "label": "Waitlist Control - delayed education",
                    "type": "OTHER",
                    "description": "Education sessions starting \\~ week 12 of trial",
                    "interventionNames": [
                        "Behavioral: Educational Session"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Educational Session",
                    "description": "The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.",
                    "armGroupLabels": [
                        "Immediate Education",
                        "Waitlist Control - delayed education"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Patient Global Impression of Change (PGIC) score",
                    "timeFrame": "Up to 14 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Self-report of pain (intensity or severity) from a numerical rating scale of 0-10",
                    "description": "Self report of pain from a numerical rating scale of 0-10 over 7 day epochs where a higher number score indicates more pain",
                    "timeFrame": "Up to 14 weeks"
                },
                {
                    "measure": "Anxiety as measured by the score on the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile version 2.1",
                    "timeFrame": "Up to 14 weeks"
                },
                {
                    "measure": "Pain interference trends as measured by the score on the PROMIS-29 Profile version 2.1",
                    "timeFrame": "Up to 14 weeks"
                },
                {
                    "measure": "Sleep disturbance as measured by the score on the PROMIS-29 Profile version 2.1",
                    "timeFrame": "Up to 14 weeks"
                },
                {
                    "measure": "Suicidal ideation as measured by the Positive and Negative Suicide Ideation (PANSI) - Positive ideation",
                    "timeFrame": "Up to 14 weeks"
                },
                {
                    "measure": "Suicidal ideation as measured by the Positive and Negative Suicide Ideation (PANSI) - Negative ideation",
                    "timeFrame": "Up to 14 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* United States Veteran\n* Experiencing chronic pain (pain lasting 3 or more months)\n* Moderate to severe chronic pain\n* Are planning or currently using cannabidiol (CBD) or cannabis products for pain management\n* Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions\n* Willingness to attend all study visits (conducted virtually)\n* Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details)\n\nExclusion Criteria:\n\n* Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English)\n* Participant states participant is pregnant\n* Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition)\n* Current diagnosis or past history of bipolar disorder\n* Unable to attend study visits\n* Risk for imminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members\n* Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Vivian Kurtz",
                    "role": "CONTACT",
                    "phone": "734-998-7156",
                    "email": "vkurtz@umich.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kevin Boehnke, PhD",
                    "affiliation": "University of Michigan",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48105",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vivian Kurtz",
                            "role": "CONTACT",
                            "phone": "734-998-7156",
                            "email": "vkurtz@med.umich.edu"
                        },
                        {
                            "name": "Kevin Boehnke",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000059350",
                    "term": "Chronic Pain"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M29442",
                    "name": "Chronic Pain",
                    "asFound": "Chronic Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5449",
                    "name": "Marijuana Abuse",
                    "relevance": "LOW"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5445",
                    "name": "Cannabidiol",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}